K. Arasteh

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks (2005)

Trottier, B., Walmsley, S., Reynes, J., Piliero, P.J., O'Hearn, M., Nelson, M., ...

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia (2003)

Lazzarin, A., Clotet, B., Cooper, D., Reynes, J., Arasteh, K., Nelson, M., ...

Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples.

Michel, D, Marre, E, Hampl, W, Roczkos, J, Müller, S, Hertenstein, B, ...

Cytomegalovirus (CMV) PCR from stool specimens was adopted as a diagnostic tool for patients with suspected CMV colitis. After being established, the method was evaluated in 17 AIDS patients and 19...

High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up.

Bek, B, Boeckh, M, Lepenies, J, Bieniek, B, Arasteh, K, Heise, W, ...

Cytomegalovirus (CMV) antigenemia was evaluated in 174 patients positive for human immunodeficiency virus. Antigenemia could be detected in 96.7% of patients with CMV disease, 76.9% of patients...

Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples.

Michel, D, Marre, E, Hampl, W, Roczkos, J, Müller, S, Hertenstein, B, ...

Cytomegalovirus (CMV) PCR from stool specimens was adopted as a diagnostic tool for patients with suspected CMV colitis. After being established, the method was evaluated in 17 AIDS patients and 19...

High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up.

Bek, B, Boeckh, M, Lepenies, J, Bieniek, B, Arasteh, K, Heise, W, ...

Cytomegalovirus (CMV) antigenemia was evaluated in 174 patients positive for human immunodeficiency virus. Antigenemia could be detected in 96.7% of patients with CMV disease, 76.9% of patients...